PhotoCure - Efficient cancer gene therapy induced by the PCI technology
Oslo, Norway, 28 March 2006. PhotoCure is, together with its subsidiary PCI Biotech, developing a proprietary technology for site-specific drug delivery and drug enhancement called Photochemical Internalisation (PCI). In a scientific article published in the leading gene therapy journal "Molecular Therapy" it is now demonstrated that PCI can be used for enhancing gene therapy of cancer. Thus, in an animal model the employment of the PCI technology improved an otherwise non-functional gene therapy to a level where more than 80 % of the animals were cured from their tumours. Gene